Kaveri Pohlman, PhD

Contact Us

Kaveri Pohlman, PhD, is a Director and BTIG Biotechnology Analyst. She provides comprehensive coverage of the biotechnology sector with a focus on large and smidcap companies. Prior to BTIG, Dr. Pohlman was a Postdoctoral Research Associate at Weill Cornell Medical College, where her research work focused on understanding the pathogenesis of various subtypes of prostate cancer, defining the molecular biology underlying the disease progression, and identifying new therapeutic targets. She earned a PhD in molecular and cell biology from SUNY Downstate Medical Center, an MS in biotechnology from New York University’s Tandon School of Engineering, and an MBA from Birla Institute of Management Technology.


Coverage Area

Company Ticker
Seagen Inc. SGEN
Ambrx Biopharma AMAM
BioAtla BCAB
Cullinan Oncology CGEM
G1 Therapeutics, Inc. GTHX
Genmab GMAB
Gritstone bio, Inc. GRTS
MacroGenics, Inc. MGNX
Mersana Therapeutics MRSN
Nuvation Bio NUVB
Replimune Group, Inc. REPL
Arcus Biosciences, Inc. RCUS
Shattuck Labs STTK
Sonnet BioTherapeutics SONN
Xencor, Inc. XNCR